Zusammenfassung
1880 wurden von Ord erstmals die pathologisch-anatomischen Veränderungen beim sog. Myxödemherzen beschrieben. 1918 hat Zondek, nachdem bereits Falta auf Kreislaufveränderungen beim Myxödem hingewiesen hatte, als erster die für das Myxödem charakteristischen klinischen, röntgenologischen und elektrokardio- graphischen Befunde, die im Wesentlichen bis heute ihre volle Gültigkeit bewahrt haben, als eigentKches Krankheitsbild dargestellt. Seither ist eine kaum übersehbare Zahl von Publikationen über die Klinik des Myxödemherzens erschienen (wir zitieren hier nur die wichtigsten: Andrus, Assmann, Bansi, Bauer, Braid, Calvert, Coelho, Curschmann, Fahr, Gordon, Hallock, Hamburger e. c., Holzman, Lerman, Lesser and Anderson, Means, Meissner, Ohler und Abramson, Richard, Schittenhelm und Eisler, Tung, Werner, Weyker, Zandrén U. a.). Dabei lag im allgemeinen das Hauptgewicht auf der Symptomatologie des voll entwickelten Myxödemherzens bei schweren und schwersten Hypofunktionszuständen der Schilddrüse. In der letzten Dekade hat das Interesse für Schilddrüsenfunktionsstörungen erneut stark zugenommen dank der bedeutenden Fortschritte, die in der funktionellen Diagnostik dieses Organs erzielt wurden, und ebenfalls dank der stark geförderten Kenntnisse des Jod- und Schilddrüsen- Stoffwechsels im allgemeinen.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Abelin, I., u. M. Goldstein: Über die Rolle des Adrenalins bei der Hyperthyreose. Klin. Wschr. 1956, 1000.
Abrami, P., M. Brulé et J. Heitz: Deux cas d’angine de poitrine avec myxoedème. Aggravation de l’hypertension par l’opothérapie. Buu. Soc. méd. Hop. Paris 49, 712 (1925).
Adlersberg, D., E. T. Bossak, I. H. Sher and H. Sobotblà.: Electrophoresis and Monomolecular Layer Studies with Serum Lipoproteins. Clin. Chemistry 1, 18 (1955).
Aikawa, J. K.: The Nature of Myxedema: Alterations in the Serum Electrolyte Concentrations and Radiosodium Space and in the Exchangeable Sodium-Potassium Contents. Ann. Int. Med. 44, 30 (1956).
Allison, F. G.: Myxedema Heart, Atrial Spetal Defect and Hypertension and Congestive Heart Failure. Amer. Heart J. 41, 620 (1951).
Altschule, M. D., and M. Volk: The minute volume output and the work of the heart in hypothyroidism. J. Clin. Invest. 14, 385 (1935).
Andbus, E. C.: The Thyroid and the Circulation. Circulation (New York) 7, 437 (1953).
Assmann, H.: Das Myxoedemherz. Münch, med. Wschr. 1919, 9.
Aub, J. C., and N. S. Stern: The Influence of Large Doses of Thyroid Extract on the Total Metabolism and Heart in a Case of Heart Block. Arch. Int. Med. 21, 130 (1918).
Aumann, K. W., and W. B. Yotjmans: Differential sensizitation of adrenergic neuroeffector systems by thyroid hormone. Amer. J. Physiol. 131, 394 (1940).
Ayman, D., H. Rosenblitm and M. Palcon-Lesses: “Myxedema Heart” Without Evidence of Cardiac Insufficiency. Report of Two Cases. J. Amer. Med. Assoc. 98, 1721 (1932).
Bansi, H. W.: Zur Pathogenese, Pathophysiologie und Klinik der Hypothyreosen. Münch, med. Wschr. 1955, 97, 1130.
Bansi, H. W.:Krankheiten der Schilddrüse. In Handbuch der Inneren Medizin, Bd. 7, 1. Teil. Springer-Verlag 1955.
Bansi, H. W.: Die Kreislaufgeschwindigkeit beim Morbus Basedow und beim Myxoedem. Z. klin. Med. 116, 583 (1931).
Bansi, H. W.: Die Krankheiten der Schilddrüse. In Handbuch der Inneren Medizin, Bd. 7, I.Teil. Springer-Verlag 1955.
Bansi, H. W. u. F. Fretwtjrst: Zur klinischen Chemie der Hypothyreose. Klin. Wschr. 1954, 887.
Bansi, H. W. u. G. Grosourth: Die Kreislaufleistung beim Basedow und Myxoedem. Z. klin. Med. 116, 583 (1931).
Barker, S. B., J. F. Fazekas and H. E. Himwich: Metabolie Aspects of Thyroid Adrenal interrelationsships. Amer. J. Physiol. 115, 415 (1936).
Barr, D. P.: Some Chemical Factors in the Pathogenesis of Atherosclerosis. Circulation (New York) 8, 641 (1953).
Barr, D. P.: Hormonal Factors in the Pathogenesis of Atherosclerosis. Minnesota Med. 38, 788 (1955).
Barr, D. P., E. M. Rfss and H. A. Eder: Protein-Lipid relationsship in human plasma. II. In aterio- sclerosis and related conditions. Amer. J. Med. 11, 480 (1951).
Bartels, J. H. and A. Bell: Zit. nachE. C. Andrus: The Thyroid and the Circulation. Circulation (NewYork) 7,437 (1953).
Bauer, J.: Das Kropf herz, seine Fehldiagnose und seine Behandlung. Med. Klin. 1953, 1846.
Behr, E., J. Mulber: Het Myxoedemhart een pathologisch-anatomische Bijdrage. Nederl. Z. Geneesk. 1938, 4303.
Ben-Asher, S.: Further Observations on Treatment of the anginal Syndrom with Thiouracil. Amer. Heart. J. 33, 490 (1947).
Benson, W.: Beitrag zur Kenntnis der Organ Veränderungen nach Schüddrüsen-Exstirpation bei Kaninchen. Virchows Arch. 170, 229 (1902).
Bing, R. J.: Der Myokardstoffwechsel. Klin. Wschr. 1956, 1.
Blackford, J. M., and F. A. Willius: Chronic Heart Block. Amer. J. Med. Sei. 154, 585 (1917).
Blalock, A., and T. R. Harrison: Regulation of Circulation Effects of Thyroidectomy and Thyroidectomy and Thyroid Feeding on Cardiac Output. Surg. etc. 44, 1617 (1927).
Blum, F.: Über Nieren-Veränderungen bei Ausfall der Schilddrüsentätigkeit. Virchows Arch. 166, 403 (1901).
Blumgart, H. L.: The Velocity of blood flow in health and disease: The velocity of blood flow in man and its relation to other measurements of the circulation. Medicine 10, 1 (1931).
Blumgart, H. L., and A. S. Freedberg: The Heart and the Thjnroid, with particular reference to J131 Treatment of Heart Disease. Circulation (New York) 6, 222 (1952).
Blumgart, H. L., and A. S. Freedberg,. and C. S. Kurland: Hypothyroidism produced by radioactive iodine (I131) — in treatment of euthyroid patients with angina pectoris and congestive heart failure. Circulation (New York) 1, 1105 (1950).
Blumgart, H. L., and A. S. Freedberg: Hypercholesterinemia, Myxedema and Atherosclerosis. Amer. J. Med. 14, 665(1953).
S. L. Gargill and D. R. Gilligan: Studies on the velocity of blood flow. XIV: The Circulation in myxedema and thyrotoxicosis. J. Clin. Invest. 9, 91 (1930).
Boyd, E. M., and W.F. Cornell: Thyroid Disease and blood lipids. Quart. J. Med. 29, 455 (1936).
Brat, L.: Das Herz bei Myxoedem. Dtsch. Arch. klin. Med. 200, 652 (1953).
Braid, F.: Hypothyroidism in Childhood. Brit. Med. J. 1951, No. 4716, 1169 (1951).
Brewer, D.B.: Myxedema: An autopsied report with histochemical observations on the nature of the mucoid infiltrations. J. of Path. 63, 503 (1951).
Brewster, W. R. Jr., J. P. Isaacs, P. F. Osgood and T. L. King: The Hemodynamic and Metabolic Interrelationsships in the Activity of Epinephrine, Norepinephirne and the Thyroid Gland. Circulation (New York) 13, 1 (1956).
Büchner, F.: Spezielle Pathologie. München und Berlin: Urban & Schwarzenberg, 1955.
Büchner, F.:Allgemeine Pathologie, 2. Aufl. München und Berlin: Urban & Schwarzenberg 1956.
Bullrich, R. H., R. Repetto and J. A. Ferrari: Myxedematous effusion. Chronic Cardiac Tamponade. Prensa méd. argent. 31, 2423 (1944).
Burlage, S. R.: The Caracteristic Electocardiogramm of the Cretin Sheep. Proc. Soc. Exper. Biol. a. Med. 19, 425 (1922).
Byrom, F. B.: The Nature of myxedema. Clin. Sci. 1, 273 (1933).
Calvert, R. J., E. Smith and G. Andrews: Coexistant Myxedema Heart Disease and Psychosis. Brit. Med. J. 1954, 891.
COELHO, E.: Les troubles cardiaques dans la maladie de Basedow et le Myxoedème. Ann. de Méd. 30, 3 (1931).
Corcoran, A. C., and I. H. Page: Specific renal function in Hyperthyroidism and Myxedema. J. Clin. Endocrin. 7, 801 (1947).
Cori, G.: Experimentelle Untersuchungen in einem kongenitalen Myxoedem. Z. exper. Med. 25, 150 (1921).
Courcy, J. L. de: Thyroidectomy in the mental disturbed with exophthalmic goiter. Amer. J. Surg. 6, 21 (1929).
Creech, O. Jr., W. H. Hicks, H. B. Snyders and E. E. Erickson: Cholesterol Pericarditis. Successful Treatment by Pericardectomy. Circulation (New York) 12, 193 (1955).
Curschmann, H.: Über Myxoedem der Erwachsenen. Med. klin. 1926, 559.
Curtis, R. H.: Hyponatremia in Primary Myxedema. Ann. Int. Med. 44, 376 (1956).
Dalla, V.: Das -Syndrom der Herzvergrößerung bei Myxödem des Erwachsenen. Wien, med. Wschr. 1943, 301.
Davidson, J. D., W. Meyer and F. E. Kendall: Effect of choline upon experimental arteriosclerosis. Circulation (New York) 3, 332 (1951).
Davis, J. C.: Myxedema Heart with Report of one Case. Ann. Int. Med. 4, 7 (1931).
Davis, C. E., J. MacKinnon and M. M. Patts: Renal Circulation and Cardiac Output on “Low output” Heart Failure and Myxoedema. Brit. Med. J. 1952, 595.
Deane, H. W., and R. O. Greep: A cytochemical study of the adrenal cortex inhypo-and h5rperthyToidism. Endocrinology (Springfield, Ill.) 41, 243 (1947).
Despopoulos, A., and W. H. Perlofp: Pituitary versus primary Myxedema. Amer. J. Med. Sci. 220, 208 (1950).
DeVisscher, M.: Rôle de la sécrétion thyroidienne dans l’action métabolique de l’adrénaline. C. r. Soc. Biol. (Paris) 140, 1205 (1946).
Dietrich, W.: Pluriglanduläre Sklerose bei Myxoedem mit mucoider Degeneration der Skelettmuskulatur. Virchows Arch. 307, 566 (1941).
Doerr, W., u. K. Holldack: Über das Myxoedemherz. Virchows Arch. 315, 651 (1948).
Doxiades, L., u. C. pototzky: Die Benutzung der kardiovasculären Untersuchungsmethoden für die Beurteilung des Myxoedems beim Kinde. Klin. Wschr. 1927, 1326.
Drake, E. H.: A Case of Complete Heart Block with Interesting Reactions to Drugs. Amer. Heart J. 31, 560 (1928).
Dyson, A., and M. W. W. Wood: Triiodothyronine in Myxedema Coma. Lancet 271, No. 6946, 757 (1956).
Eiselberg, a. F.: Über Wachstumsstörungen bei Tieren nach frühzeitiger Schilddrüsen-exstirpation. Arch. klin. Chir. 49, 207 (1895).
Ellis, L. B., J. G. Mebaine, G. Maresk, H. N. Hultgren and R. A. Bloomfield: The effect of myxedema on the cardiovascular system. Amer. Heart. J. 43, 1 (1952).
Engelberg, H., H. B. Jones and B. J. Gofman: Circulation (New York) 4, 477 (1951); zit. nach H. Weicker.
Epstein, A. A., and H. Lande: Studies on blood lipoids. I. The Relation of cholesterol and protein deficiency to basal metabolism. Arch. Int. Med. 30, 563 (1922).
Evans, W.: The Heart in Endocrine Disaese. Proc. Roy. Soc. Med. 42, 331 (1949);
Evans, W.:A Case of Myxedema with Ascites and Atony of the Urinary Bladder. Endocrinology (Springfield, Ill.) 16, 409 (1932
Evans, W.: Myxedema Heart Disease, Treatment and Radiographic Changes. Lancet 1937 II, 1300.
Fahr, G.: Myxedema Heart. J. Amer. Med. Assoc. 84, 345 (1925);
Fahr, G.:Myxedema Heart. Amer. Heart. J. 3, 14 (1927).
Falta, W.: Die Erkrankungen der Blutdrüsen. 1913.
Feasley, w. r.: Pericardial Effusion in myxedema. Amer. Heart J. 19, 749 (1940).
Ferayorini, R. R., and R. G. Sprague: Myxedema with Ascites and Hydrothorax. Proc. Staff Meet. Mayo Clin. 27, 25 (1952).
Fishberg, a. M.: Arteriosclerosis in Thyroid Deficiency. J. Amer. Med. Assoc. 82, 463 (1924).
Foster, M., and Barr, D. P.: Myxedema; record of an autopsied case with special emphasis upon lesions of muscles. J. Clin. Endocrin. 4, 417 (1944).
Fraser, R. W., A. P. Forbes, F. Albright, H. Sulkowitch and E. C. Reifenstein: Colorimetrie assay of 17-ketosteroids in urine. J. Clin. Endocrin. 1, 234 (1941) 4 Fbank Schaub:
Frebdman, H. H., and A. S. Gordon: Effects of thyroidectomy and of thiom-acil on adrenal weight and ascorbic acid. Proc. Soc. Exper. Biol. a. Med. 75, 729 (1950).
Freeman, E. B.: Chronic Pericardial Effusion in Myxedema. Ann. Int. Med. 7, 1070 (1934).
Frisk, A. R., and I. Lindgren: Methylthiouracil in treatment of congestive heart failure and angina pectoris; results of prolonged treatment. Acta med. scand. (Stockh.) 132, 69 (1948).
Froment, R.: Le gros coeur myxoedemateux. Myxoedeme myocardique. Méd. Lyon 1936, 619.
Gascard, E., et L. Pierron: La péricardite myxoedémateuse. Paris méd. 1951, 35.
Gibson, H. G., and A. W. Harris: Clinical Studies of the Blood Volume. V. Hyperthyroidism and myxedema. J. Clin. Invest. 18, 59 (1939).
Gildea, E. F., E. B. Man and J. P. Peters: Serum lipoids and proteins in hypothyroidism. J. Clin. Invest. 18, 739 (1939).
Gofman, J. W., F. T. Lindgren, H. A. Elliott, W. Mantz, J. Hewitt, B. Strisower and V. Herring: The Role of lipids and lipoproteins in atherosclerosis. Science (Lancaster, Pa.) 3, 166 (1950).
H. B. Jones, F. T. Lindgren, T. P. Lyon, H. A. Elliott and B. Strisower: Blood lipids and human atherosclerosis. Circulation (New York) 2, 161 (1950).
H. B. Jones, F. T. Lindgren, T. P. Lyon, H. A. Elliott and B. Strisower., T. P. Lyon, F. Lindgren, B. Strisower, D. Coman and V. Herring: Blood lipids and human atherosclerosis. Circulation (New York) 5, 119 (1952).
Goldberg, S. A.: Changes in organs of thyroidectomized sheep and goats. Quart. J. Exper. Physiol. 17, 15 (1927).
Goldberg, S. A., and I. L. Chaikofp: Myxedema in the radio-thioidectomized dog. Endocrinology (Springfield, lII.) 50, 115 (1952).
Gordon, A. H.: Some clinical aspects of hypoth3rroidism. Canad. Med. Assoc. J. 20, 7 (1929);
Gordon, A. H.:Pericardial effusion in Myxedema. Trans. Assoc. Amer. Physicians 50, 272 (1935).
Gräsbeck, R., and B. A. Lamberg: The Electrophoretic Lipoprotein Pattern in Disorders of Thyroid Function. Acta endocrinol. (Copenh.) 19, 82 (1955).
Hallock, p.: The Heart in Myxedema with a Report of two Cases. Amer. Heart J. 9, 196 (1933).
Hamburger, W. W., M. W. Lev, W. S. Priest and H. C. Hovard: The Heart in Thyroid Disease. Arch. Int. Med. 43, 1 (1929).
Harrell, G. T., and C. Johnston: Pericardial Effusion in Myxedema. Amer. Heart J. 25, 505 (1943).
Heckscher, H.: Über die Fett-Cholesterinmenge des Blutes bei Eó-etinen. Z. Biochem. 158, 422 (1928).
Higgins, W. H.: The Heart in Myxedema. Amer. J. Med. Sci. 191, 80 (1936).
Hoelzer, H.: Über die Arteriosklerose im Kindesalter bei angeborenem vollkommenem Schilddrüsenmangel. Zugleich ein Beitrag zur Funktion der Schilddrüse und zur Arteriosklerosis- frage. Beitr. path. Anat. 104, 289 (1940).
Hoffman, F., E. J. Hoffman and J. Talesnik: The influence of thyroxine and cortical extract on the oxygen consumption of adrenalectomized rats. J. of Physiol. 107, 251 (1948).
Hoffman, F., E. J. Hoffman and J. Talesnik., O. Cori and A. T. de Cori: Acta physiol. lat.-amer. 1, 84 (1951); zit nach Abelin u. Goldstein.
Holldack, K.: Beobachtungen am Myxoedemherzen. Dtsch. med. Wschr. 1949, 16.
Holzman, J. E.: Myxedema Heart. Amer. Heart J. 4, 351 (1929).
Holzmann, M.: Klinische Elektrokardiographie. Thieme-Verlag 1956.
Holzmann, M.:Erkrankungen des Herzens und der Gefäße, in H. R. Schinz, W. E. Baensch, E. Friedl, E. Uehlinger: Lehrbuch der Röntgendiagnostik, Bd. III. Stuttgart: Georg Thieme 1952.
Horstman, P.: The Effect of Adrenaline on the Oxygen Consumption in Diabetes mellitus and in Hyperthyroidism. Acta endocrinol. (Copenh.) 16, 233 (1954).
Houssay, H. E. J.: Tiroides e hipertrofia cardiaca. Rev. argent. Cardiol. 22, 34 (1955).
Hurxthal, L. M.: Blood cholesterol in thyroid disease. III. Myxedema and hyperchol- esterinemie. Arch. Int. Med. 53, 762 (1934).
Jahnke, K.: Klinische Ultrazentrifugen-Untersuchungen. III. Mitteilungen. Die Lipoid- proteine im Serum, ihre Differenzierung und klinische Bedeutung. Z. exper. Med. 125, 59 (1955).
Jeffers, W. A., E. Rose and Littman, D. S.: Infrequency of Myocardial Infarction in Patients with Thyrotoxicosis. Circulation (New York) 14, 957 (1956).
Ingle, D. J., and G. M. Higgins: The Effects of Thyroxin on the extent of Regeneration in the enucleated Adrenal Gland of the Rat. Endocrinology (Springfield, Ill.) 41, 243 (1947).
Jones, R. J., L. Cohen and H. Corbus: The Serum Lipid Pattern in Hyperthyroidism, Hypothyroidism and Coronary Atherosclerosis. Amer. J. Med. 14, 71 (1955).
Jores, A.: Handbuch der Inneren Medizin, Bd. 7, I.Teil. Berlin-Göttingen-Heidelberg: Springer 1955.
Kaunitz, H.: Hydroperikard bei inrektorischer Störung. Z. klin. Med. 130, 601 (1936).
Kern, R. A., L. A. Soloff, W. J. Snape and C. T. Bello: Pericardial Effison: a constant, early and major factor in the cardiac syndrome of hypothyroidism (myxedema heart). Amer. J. Med. Sci. 217, 609 (1949).
Kimble, S. T., and E. J. Stieglitz: Hypothyroidism: a Geriatric Problem. Geriatrics 7, 20 (1952).
Klein, E.: Die Elektrophorese der Serumlipoproteine. Dtsch. med. Wschr. 1956, 1808.
Kleinsorg, H., H. L. Krüskemper, C. Lopez-Calle ja: Serumeiweißveränderungen bei experimenteller Hypothyrose nach Zufuhr von Jod131. Acta endocrinol. (Copenh.) 19, 157 (1955).
Knight, R. A.: The Use of Spinal Anaesthesia to Control Sympathetic Overactivity in Hyperthyroidism. Anesthesiology 6, 225 (1945).
Korrodi, H.: Der Radiojodtest in der Diagnose latenter Hypothyreosen. Helvet. med. Acta 21, 4/5, 419 (1954).
Korth, C., J. Schmidt: Neue Beobachtungen zum,,Myxoedemherzen”. Dtsch. Arch, klin. Med. 202, 437 (1955).
Kountz, W. B.: Vascular degeneration in hypothyroidism. Arch. Path. 50, 765 (1952).
Kountz, W. B.:Thyroid Function and its possible Role in Vascular Degeneration. Springfield, Ill.: Charles C. Thomas 1954.
Kountz, W. B., and L. H. Hepelmann: Chromatic degeneration and rupture of aorta following thyreoidectomy in cases of hjrpertension. Amer. Heart J. 20, 599 (1940).
Krane, S. M., G. L. Brownell, J. B. Stanbury and H. Corrigan: The Effect of Thyroid Disease on Calcium Metabolism in Man. J. Clin. Invest. 35, 874 (1956).
Kroetz, C., u. W. Fischer: Zur Blutchemie der akuten, fortschreitenden Arteriosklerose, elektrophoretische Lipoproteinbestimmungen bei Atheromatose und Atherosklerose. Dtsch. med. Wschr. 1954, 633.
Kroneberg, G., u. F. Huter: Der Einfluß von Thyroxin auf die Toxicität des Adrenalins und des Arterenols. Klin. Wschr. 1951, 649.
Krüskemper, H. L.: Untersuchungen über die Beziehungen zwischen Schilddrüsen- und Nebennierenrinden-Hormon Wirkungen im Gewebestoffwechsel. Acta endocrin. (Copenh.) 19, 21 (1955).
Kurland, G. S., R. E. Schneckloth, A. S. Freedberg: The Heart in I131 Induced Myxedema. New England J. Med. 249, 215 (1953).
Labhart, A.: Klinik der inneren Sekretion. Berlin-Göttingen-Heidelberg: Springer 1957.
LaDue, J. S.: Myxedema Heart: A pathological and therapeutic Study. Ann. Int. Med. 18, 332 (1943).
Lamberg, B. a., and R. Gräsbeck: The Serum Protein Pattern in Disorders of Thyroid Function. Acta endocrinol. (Copenh.) 19, 91 (1955).
Lange, K.: Capillary Permeability in Myxedema. Amer. J. Med. Sei. 208, 5 (1944).
Laubry, C., Mussio-Fournier et J. Walser: Syndrome angineux et insuffisance thyroidienne. BuU. Soc. Hop. Paris 48, 1592 (1924).
Lemaire, a., et J. Cottet: Le syndrome biochimique de l’athérosclérose animale. Presse méd. 1955, 1339.
Lemaire, a., et J. Cottet., et S. Led ermann: Le syndrome biochimique de l’athérosclérose humaine. Presse méd. 1956, 1129.
Enselme, J. Cottet, P. Cassassus et Tigaud: Les lipoprotéines du sérum, leur étude par électrophosphorèse de zone sur papier. Ann. de Méd. 57, 5 (1956).
Le Marquand, H. S., W. Hausmann and E. H. Hemsted: Death in Myxedema. Brit. Med. J. 1953, 704.
Lerman, J:. J Amer. Med. Assoc. 117, 349 (1941); zit. Nach
M. Richard, Die Hypothyreose. Schweiz, med. Wschr. 1952, 913.
Lerman, J: Myxedema Heart. J. Clin. Endocrin. 14, 477 (1954).
R. J. Clark, and J. H. Means: The Heart in Myxedema: Electrocardiogramme and Röntgen ray measurements before and after therapy. Ann. Int. Med. 6, 1291 (1933).
Lesser, H., and E. M. Anderson: Three Cases of Adult Myxedema in Women. Endocrinology (Springfield, Ill.) 15, 5 (1931).
Levin, M. E., and W. H. Daughady: Fatal Coma Due to Myxedema. Amer. J. Med. 18, 1017 (1955).
Lewis, L. A., A. A. Green and I. H. Page: Ultracentrifuge Lipoprotein Pattern of Serum of normal, hjrpertensive and hjrpothyroid animal. Amer. J. Physiol. 171, 391 (1952).
Lijung, O.: Mild Hypothyroidism causing Electrocardiographic Changes Suggesting Coronary Insufficiency. Acta med. scand. (Stockh.) 137, 120 (1950).
Littmann, D. S. e. c.: The Infrequency of Myocardial Infarction in Patients with Thyrotoxicosis. Amer. J. Med. Sci. 233, 10, (1957).
Lueg, W.: Über das Elektrokardiogramm des Myxoedems. Z. klin. Med. 104, 337 (1926).
Luetscher, J. A. Jr., and R. h. Curtis: Aldosterone; Observations on the Regulation of Sodium and Potassium Balance. Ann. Int. Med. 43, 658 (1955).
Luten, D.: Myxedema with Partial Heart Block and Severe Anemia Both of which disappeared under thyroid therapy. J. Missouri Med. Assoc. 26, 73 (1920).
Lutolf, W.: Untersuchungen über die Sensibilisierung von Adrenalin durch Thyroxin am überlebenden Säugetierherzen. Z. Biol. 90, 334 (1930).
Macy, J. W., T. S. Claiborne and L. M. Hurxthal: The Circulation Rate in Relation to Metabolism in Thyroid and Pituitary States (Decholin Methode). J. Clin. Invest. 15, 37 (1936).
Madenberg, F.: Occurrence of Ascites in Myxedema. Arch. Int. Med. 93, 787 (1954).
Mahaux, J., et E. Koiw: Protéinogramme et lipidogramme sur papier filtre dans le myx- oedème. Action de la thyroxine’. Ann. d’Endocrin. 13, 691 (1952).
Malden, M.: Hypothermic Coma in Myxedema. Brit. Med. J. No. 4942, 764, 1955.
Malbcros, H., and B. Swahn: Lipid metabolism in myxedema. Acta med. scand. (Stockli.) 145, 361 (1953).
Mancini, R. E., J. C. Garb eri and F. A. de la Balze: Mucoproteines of the connective tissue of the skin in generalized myxedema. J. Nat. Cancer Inst. 13, 247 (1952).
March, H. E.: Myxedematous Ascites Removed by Thyroid Extract. Amer. J. Med. Sci. 172, 585 (1926).
Marchand, F.: Über einen Fall von sporadischem Kretinismus und Myxoedem mit fast totaler Aplasie der Schilddrüse. Münch, med. Wschr. 1440, 1906.
Margitay-Becht, A.: Der Natriumgehalt des Blutserums bei Myxoedem. Klin. Wschr. 1937, 1353.
Marks, P. A., and B. S. Roff: Pericardial effusion associated with myxedema. Ann. Int. Med. 39, 230 (1953).
Marshall, R. J., McCaughey W. T. E.: Hjrpothermic Myxedema Coma with Muscle Damage and Acute Renal Tubular Necrosis. Lancet 1956, 6946, 754.
Martius, C.: Die Wirkungsweise desSchüddrüsenhormones, in:Hormone und ihre Wirkungsweise. Berlin-Göttingen-Heidelberg: Springer 1955.
Marzullo, E. R., and S. Franco: Myxedema with multiple serous effusions and cardiac involvement (myxedema heart) Case Report. Amer. Heart J. 17, 368 (1939).
McCubbin, j. W., and I. H. Page: Effect of athyroid state on vascular reactivity and arterial pressure in neurogenic and renal hypertensive dogs. Circulation (New York) 5, 397 (1952).
McGavack, T. H.: The Thyroid. St. Louis: Mosby 1951.
McGavack, T. H., K. Lange and D. Schwimmer: Management of the Myxedematous Patients with Symptoms of Cardiovascular Disease. Amer. Heart. J. 29, 421 (1945).
McGavack, T. H., Means, J. H.: The Thyroid and its Disease. Philadelphia: J. B. Lippincot Co. 1948.
McGavack, T. H:Hypothyroid Heart Disease. New England J. Med. 208, 541 (1933).
P. D. White and C. Krantz: Observations on the Heart in Mxyedema with Special Reference to Dilatation and Angina pectoris. Boston Med. J. 195, 351 (1926).
Meissner, R.: Zur Klinik des Myxoedemherzens. Münch, med. Wschr. 1920, 1316.
Merkel, H.: Beitr. path. Anat. 104, 332 (1940);
Merkel, H.: Arch. Kreislaufforsch. 9,283 (1941); zit. nach F. Büchner.
Misske, B.: Das Elektrokardiogramm des Mxyoedemherzens. Z. Kreislaufforsch. 28, 601 (1936).
Neter, E.: Untersuchungen über die reflektorische Selbststeuerung des Kreislaufes bei experimenteller Thyreotoxikose. Arch, exper. Path. u. Pharmakol. 174, 416 (1936).
Nobel, E., A. Rosenblüth u. B. Samet: Das Elektrokardiogramm des kindlichen Myxoedems. Z. exper. Med. 43, 332 (1924).
Nüss, F. J.: Die sog. Cholesterin-Perikarditis. Ärztl. Forsch. 9,1, 526 (1955).
Ohler, W. R., and J. Abramson: The Heart in Myxedema. Arch. Int. Med. 53, 165 (1934).
Oliver, M. F., and G. S. Boyd: The Influence of Triiodothyroacetic Acid on the Circulating Lipids and Lipoproteins in euthyroid men with coronary disease. Lancet 1957, No. 6960, 124.
Ord, W. M.: Cases of Myxedema. Trans. Clin. Soc. London 13, 15 (1880).
Page, I. H.: Atherosclerosis. An Introduction. Circulation (New York) 10, 1 (1954).
Page, I. H., and H. B. Brown: Induced Hypercholesterolemia and Atherogenesis. Circulation (New York) 6, 681 (1952).
Page, I. H.:and J. W. McCubbin: Influence of Thyroid Function on Vascular Reactivity in Dogs. Circulation (New York) 3, 397 (1952).
Parsons, W. H., and W. K. Purks: Total Thyroidectomy for heart disease. Ann. Surg. 105, 722 (1937).
Paterson, J. C., B. B. Cornisk and E. C. Armstrong: The Serum Lipids in Human Atherosclerosis. Circulation (New York) 13, 224 (1956).
Pathy, M. S.: a Case of Myxedema with Serous Effusions. Brit. Med. J. 1955, No. 4942, 772.
Pekkarinen, a., M. Koivusolo and K. Pyorola: Investigation of the Effect of Thyroid Preparations and of Methylthiouracil on the Adrenal Glands and Chemistry as well as on some others Organs. Acta endocrinol. (Copenh.) 6, 233 (1951).
Peltola, p.: Adrenal sensitization induced by Experimental Herthyroidism. Acta med. scand. (Stockh.) 140, Suppl. 262 (1951).
Pick, E., u. P. Pineles: Untersuchungen über physiologisch wirksame Substanz der Schilddrüse. Z. exper. Path. u. Ther. 7, 518 (1909).
Pick, E., u. P. Pineles:Über die Beziehungen der Schilddrüse zum Gefäßsystem. 25. Kongreß inn. Med. 25, 306 (1908).
Pickering, D. E., D. A. Fisher and K. G. Scott: Growth and Metabo Hsm in normal and Thjnroid-ablated Infant Rhesus Monkey (Macaca mulatta). Amer. J. Dis. Childr. 86, 157 (1984)
Pratt, G. P., and H. B. Morton: Management of the Circulation in Myxedema. Amer. J. Med. Sci. 173, 274 (1927).
Preston, M. I.: Effects of Thyroxin on the mouse Adrenal. Endocrinology (Springfield, lII.) 12, 323 (1928)..
Raab, W.: Epinephrine Tolerance of the Heart altered by Thyroxine and Thiouracil. J. Pharmacol, a. Exper. Ter. 82, 330 (1944).
Raab, W.:Diminuition of Epinephrine Sensitivity of normal Human Heart through thiouraco. J. Labor, a. Clin. Med. 30, 774 (1945).
Raab, W.:Hormonal and Neurogenic Cardiovascular Disorders. Baltimore: Williams and Wilkins 1953.
Ramey, E. R., H. Bernstein and M. S. Goldstein: Effect of Sympathetic Blocking Agents on the Increased Oxygen Consumption following Administration of Thyroxine. Federat. Proc. 14, 118 (1955).
Ravéra, J. J.: Myxoedème avec insuffisance cardiaque, angine de poitrine et épanchement pleural. Evolution favorable par le traitement thyroïdien. BuU. Acad. Nat. Méd. 138, 537 (1957)
Rea, C. E.: A new plan in the operative treatment of patients with severe Hyperthyroidism. Surgery 16, 731 (1944).
Read, J. M.: Treatment of the Cardiac Disturbances due to Thyroid Disease. J. Amer. Med. Assoc. 89, 493 (1927).
Reid, W. D., and F. V. Kenway: Electrocardiographic Signs Associates with Low Basal Metabollsm. Endocrinology (Springfield, Ill) 13, 191 (1929).
Richard, M.: Die Hjothyreose. Schweiz, med. Wschr. 1952, 913.
Ring, G. C.: The importance of the Thyroid in Maintaining an Adequate Production of Heart During exposure to Cold. Amer. J. Physiol. 137, 582 (1942).
Robertson, J. D.: Calcium and Phosphorus Studies in Myxedema. Lancet 1941 II, 216.
Rosenblijm, H., R. G. Hahn and S.A. Levine: Epinephrine; its Effect on the Cardiac Mechanism in Experimental Hjrperthyroidism and Hypothyroidism. Arch. Int. Med. 51, 279 (1933).
Rosenman, R. H., M. Friedman and S. O. Byers: Observations concerning the Metabolism of Cholesterol in the Hjrpo- and Hyperthyroid Rat. Circulation (New York) 5, 589 (1952).
Rössle, R.: Über Myxoedem bei totaler Thyreoaplasie. Korresp. bl. ärztl.Ver. Tübingen H. 1/2 (1920).
Sainton, P., E. Doumer et P. Véran: Syndrome cardiorénal et hypothyroidie. Ann. de Méd. 24, 513 (1928).
Sato, H.: Studies on the Cardiac Rythm of the dog in Experimental Hyper- and Hjrpo- thyroidism. Tokoku J. Exper. Med. 53, 317 (1951); ref. in Circulation (New York) 5, 140 (1952).
Sawyer, M. E. M., and M.G. Brown: Effect of Thyroidectomy and Thjrroxine on the Response of the Denervated Heart to injected and secreted Adrenin. J. Amer. Physiol. 110, 620 (1935).
Schantz, E. T., and A. W. Ditbbs: Complete auriculoventricular Block in Myxedema with Reversion to normal Sinus Rhythm on Thyroid Therapy. Amer. Heart J. 41, 613 (1951).
Schaijb, F.: Über die Herzveränderungen bei Myxoedem und einfacher Hypothnreose, Cardiologia (Basel) 30, 185 (1957).
Scheinberg, P., E. A. Stead Jr., E. S. Brannon and J. V. Warren: Correlative Observations on cerebral Metabolism and cardiac output in Myxedema. J. Clin. Invest. 29, 1139 (1950).
Schermann, S. J.: Die Reaktion des isoUerten Herzens eines thyreoidectomierten Tieres auf Adrenalin. Arch, exper. Path. u. Pharmakol. 126, 10 (1927). 8 Fraiste: Schaub:
Schettler, G.: Schilddrüse und Cholesterin. Beitrag zur thyreostatischen Therapie mit Aminothiazol und Methylthiouracil. Z. exper. Med. 115, 251 (1950);
Schettler, G.:Arteriosklerose und Cholesterinstoffwechsel. Dtsch. med. Wschr. 1953, 989; Lipidosen, Handbuch der Inneren Medizin, Bd. 7, 2. Teil. Berlin-Göttingen-Heidelberg: Springer 1955; Die Pathogenese der Arteriosklerose als Stoffwechselproblem. Erg. inn. Med. N. F. 6, 278 (1955).
H. Jobst: Die Bedeutung alimentärer Fettbelastung für die Diagnose der Arteriosklerose. Dtsch. med. Wschr. 1955, 1077.
Schittenhelm, A., u. B. Eisler: Über die Wirksamkeit des Thyroxins bei endokrin bedingten Störungen. Khn. Wschr. 1927, 1935.
Schleshstger, B., and B. Landtman: Electrocardiographic Studies in Cretins. Brit. Heart J. 10, 237 (1948).
Schmidt, S.: Pericardial effusion in Myxedema. Brit. J. Radiol. 25, 389 (1952).
schneckloth, R. E., G. E. kurland and A. s. Freedberg: Effect of Variations in Thiroid Function on the Pressor response to Norepinephrine in Man. Metabolism 2, 546 (1953).
Schnitzer, R., and D. Gutman: Myxedema with Pericardial Effusion. Brit. Heart J. 8, 25 (1946).
Schultz, A.: Über einen Fall von Athyreosis congenita (Myxoedem) mit besonderer Berücksichtigung der dabei beobachteten Muskel Veränderungen. Virchows Arch. 232, 302 (1941).
Schrenwood, G.: Treatment of Angina pectoris by Reduction of Metabolism. Brit. J. Med. 1948,1251.
Seely, H., and E. C. Cutler: Effect of total Thjo-eoidectomy on Response to Injection of Adrenalm. Proc. Soc. Exper. Biol. a. Med. 34, 23 (1936).
Selenkow, H. A., u. S. P. Asper Jr.: Wirksamkeit von peroralem Trijodothjrronin und Thyroxin in der Behandlung des Myxoedems. J. Clin. Endocrin. 86, 53 (1956).
Shapiro, S.: Relation of certain Glands of Internal Secretion to the Development of Ather- sclerosis. Endocrinology 11, 279 (1927)
Shapiro, S.:Influence of Thyroidectomy, Splenectomy, Gonadectomy and Suprarenalectomy upon Development of experimental Atherosclerosis in Rabbits. J. of Exper. Med. 45, 595 (1927).
Smith, D. J.: Immediate Sensitization of isolated Swine arteries and their Vasa Vasorum to Epinephrine, Acetylcholine and Histamine by Thiroxine. Amer. J. Physiol. 177, 7 (1954).
Smyth, C. J.: Angina pectoris and myocardial infarction as complications of myxedema with special reference to treatment with thyroid preparations. Amer. Heart J. 15, 652 (1938).
Soffer, A., P. N. G. Yu and D.A. Epstein: Serum Lipid Studies in euthyroid Subjects foUowing the Administration of Thyroid. Amer. J. Med. Sei. 222, 427 (1951).
Sommerville, W., and S. A. Levine: Angina pectoris and Thyreotoxicosis. Brit. Heart J. 1, 245 (1950).
Starr, P., and R. Liebhold-Schneck: The Effect of Levo-Thyroxine, Dextrothyroxine and Levo-Jodo-Thyronine on the Electrocardiogramm in Myxedema. Preliminary Rep. Ann. Int. Med. 42, 595 (1955).
Statland, H., and J. Lerman: Function of the Adrenal Cortex in Myxedema with some Observations on pituitary Function. J. Clin. Endocrin. 10, 1401 (1950).
Steiner, A., and F. E. Kendall: Atherosclerosis and arteriosclerosis in Dogs following Ingestion of Cholesterol and Thiouracil. Arch, of Path. 42, 433 (1946).
Steiner, A., and F. E. Kendall and M. Be vans: Production of Arteriosclerosis in Dogs by Cholesterol and Thiouracil feeding. Amer. Heart J. 38, 34 (1949).
Stewart, H. J., J. E. Dietrick and N. F. Crane: Studies of the Circulation on Patients suffering from spontaneous Myxedema. J. Clin. Invest. 17, 237 (1938).
Strisower, B., J. W. Gofman, E. G. Galioni, J. H. Rubinger, J. Pouteau and P. Cuzvich: Long-Term-Effect of Dried Thyroid on Serum-Lipoprotein and Serum-Cholesterol Levels. Lancet 1957, No. 6960, 120.
Sturgis, C. C.: Angina pectoris as a Complication in Myxedema and Exophthalmus Goiter. Boston Med. J. 195, 351 (1926).
Sturgis, C. C and W. B. Whiting: The Treatment and Prognosis in Myxedema J. Amer. Med. Assoc. 85, 2013 (1925).
Swan, J. M.: Case of Auricular Fibrillation Occuring during the Administration of Thyroid Substance. Ann. Clin. Med. 3, 311 (1924).
Talbot, N. B., and A. M. Butler: J. Clin. Endocrin. 26, 129, 1940; zit. nach
M. Richard: Die Hypothjrreose. Schweiz, med. Wschr. 1952, 913.
Tatum, a. L.: Morphologic Studies in Exprimental Cretinism. J. of Exper. Med. 17,636 (1913).
Thacher, C.: The Electrocardiogramm in Cretinism and Mongolian Idiocy. Amer. J. Dis. Chüdr. 28, 25 (1924).
Thacher, C and P. D. White: The Electrocardiogramm in Myxedema. Amer. J. Med. Sei. 171, 61 (1926).
Thompson, K. W., and C.N. H. Long: Endocrinology (Springfield, Ill.) 28, 715 (1941); zit. nach Weicker Das Herz bei Myxödem und Hypothyreose 9
Thompson, W.: The Blood Volume in Myxedema with a Comparison of the Plasma Volume Changes in Myxedema and Cardiac Edema. J. Clin. Invest. 2, 477 (1926).
Thompson, W. O., L. N. P. Diceb, A. E. Mobbis and B. H. Hblvitch: The High Incidence of Hypertension in Toxic goiter and in Myxedema. Endocrinology (Springfield, Ill.) 15, 265 (1931).
Thurnhbrb, A.,u.W. Nibderbergbr: Neuere Auffassungen über Aetiologie und Therapie der Atherosklerose unter besonderer Berücksichtigung von Heparin. Schweiz, med. Wschr. 285;
Thurnhbrb, A:Lipoproteinstudien zur Ätiologie und Therapie der Arteriosklerose. Bull. Schweiz. Akad. med. Wiss. 12, 1 (1956).
Tung, C. L.: The Status of the Heart in Myxedema. Amer. Heart J. 6, 734 (1931).
Tucker, H. St. G., J. L. Chitwood and C. P. Parker: Pituitary Myxedema, Report of 3 Cases. Ann. Int. Med. 32, 52 (1950).
Urschel, D. L., and G. E. Gates: Mean Spatial Vectorcardiography. The Vector Changes in. Hypothyroidism. Amer. Heart J. 46, 611 (1953).
Walker, J. E.: Hypothyroidism associated with Cardiac Enlargement (Myxedema Heart) and Auricular FibriUation. J. Amer. Med. Assoc. 100, 1025 (1933).
Wartman, W. B., and W. T. Hill: Degenerative Diseases, in Gould, S.E.: Pathology of the Heart. Springfield, Ill.: Charles C. Thomas 1953.
Watson, E. M., and R. H. Pearce: The Mucopolysaccharide content of the Skin in localized (pretibial) Myxedema. Amer. J. Clin. Path. 17, 507 (1947).
Webster, B., and C. Cooke: Morphologic Changes of the Heart in Experimental Myxedema. Arch. Int. Med. 58, 269 (1936).
Wegelin, C.: Die Schüddrüse. In Handbuch der speziellen pathologischen Anatomie und Histologie von Henkb-Lubarsch, Bd. 8. Berlin 1926.
Weicker, H.: Die Lipoideiweißkomplexe bei Myxödem und Hyperthyreose. Acta Endocrin. (Copenh.) 22, 73 (1956).
Weicker, H.: Die Lipoproteine bei Schüddrüsenerkrankungen. Ärztl. Wschr. 1956, 100.
Werner, S. C.: The Thyroid. A Fundamental and Clinical Test. New York: P. B. Hoeber Inc.
Weyker, R. T.: Myxedema Heart. J. Amer. Med. Assoc. 153, 639 (1953).
White, P. D., and J. C. Aub: The Electrocardiogramm in Thiroid Disease. Arch. Int. Med. 22, 766 (1918).
Willius, F. A.: Thyroid Preparations in the Treatment of the Stokes-Adams-Syndrome. Canad. Med. Assoc. J. 14, 1072 (1924).
Willius, F. A.: Cardiac Clinics; Clinic in Advanced coronary Sclerosis with congestive Heart Failure in young Adult, juvenile Myxedema. Proc. Staff Meet. Mayo Clin. 11, 557 (1936).
Willius, F. A.,and S. F. Haines: Status of the Heart in Myxedema. Amer. Heart J. 1, 67 (1925).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1958 Springer-Verlag OHG. Berlin · Göttingen · Heidelberg
About this paper
Cite this paper
Schaub, F. (1958). Das Herz bei Myxödem und Hypothyreose. In: Heilmeyer, L., Schoen, R., Glanzmann, E., De Rudder, B. (eds) Ergebnisse der Inneren Medizin und Kinderheilkunde. Ergebnisse der Inneren Medizin und Kinderheilkunde, vol 9. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-94722-3_1
Download citation
DOI: https://doi.org/10.1007/978-3-642-94722-3_1
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-94723-0
Online ISBN: 978-3-642-94722-3
eBook Packages: Springer Book Archive